Increased intestinal permeability ("leaky gut") allows bacterial lipopolysaccharides (LPS) to enter the bloodstream, triggering systemic inflammation that impairs insulin signaling
Variability in Formulations One of the significant concerns regarding compounded semaglutide is the variability of its formulations
Notably, the Frias phase 2 trial in type 2 diabetes reported no level 2 or level 3 hypoglycaemia in any arm, but those participants were on metformin with or without an SGLT2 inhibitor not insulin [13]
More recently, obesity has been linked to a significant increase in the rate of hospitalizations and deaths
However, combining these treatments also carries specific risks that require careful consideration
Dehydration concentrates creatinine and BUN in the blood, potentially making them appear elevated even if kidney function is fundamentally normal